Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study-Reference-Cited by-同舟云学术

Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study

Published:2016-11 Issue: Volume:67 Page:91-98
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Trama Annalisa,Botta Laura,Nicolai Nicola,Rossi Paolo Giorgi,Contiero Paolo,Fusco Mario,Lodde Michele,Pannozzo Fabio,Piffer Silvano,Puppo Antonella,Seeber Andreas,Tumino Rosario,Valdagni Riccardo,Gatta Gemma

Funder

Associazione Italiana per la Ricerca sul Cancro

AMGEN Dompé

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11;Ferlay,2013

2. Prostate cancer incidence and mortality trends in 37 European countries: an overview;Bray;Eur J Cancer,2010

3. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

4. Prostate cancer in Italy before and during the “PSA era”: survival trend and prognostic determinants;Quaglia;Eur J Cancer Prev,2003

5. Estimates of prostate cancer burden in Italy;Capocaccia;Cancer Epidemiol,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer;Discover Oncology;2023-11-01

2. Efficacy and safety of mirabegron in the treatment of overactive bladder syndrome after radical prostatectomy: a prospective randomized controlled study;Frontiers in Oncology;2023-05-02

3. The prostate cancer landscape in Europe: Current challenges, future opportunities;Cancer Letters;2022-02

4. Darolutamide as a Second-Generation Androgen Receptor Inhibitor in the Treatment of Prostate Cancer;Current Molecular Medicine;2021-06-02

5. ECCO Essential Requirements for Quality Cancer Care: Prostate cancer;Critical Reviews in Oncology/Hematology;2020-04